What is the current share price of Alkem Laboratories Limited (ALKEM)?

As of the latest market update, Alkem Laboratories Limited (ALKEM) is trading at ₹5,669.5. The stock has moved 0.37% up in the recent session.

What is the technical sentiment for ALKEM stock?

Based on our proprietary technical analysis, the current signal for ALKEM is "BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Alkem Laboratories Limited?

Alkem Laboratories Limited has seen a 52-week high of ₹5,933.5 and a 52-week low of ₹4,716.2. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Alkem Laboratories Limited belong to?

Alkem Laboratories Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of ALKEM?

Alkem Laboratories Limited (ALKEM) has a market capitalization of approximately ₹67.79K Cr. This classifies it as a mid cap stock in the Indian market.

ALKEM

NSEF&O

Alkem Laboratories Limited (MID CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹5,669.50

21.00 (0.37%)

Medium VOLATILITY

As on 10 Jul 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹67.79K Cr

MID CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

28.7

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹4,716.2+20.2%

52W High₹5,933.5-4.4%

Current Price

₹5,669.50

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹4,535.60

Upper Circuit₹6,803.40

Reference Price

₹5,669.50

Investment Checklist

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹5975.0

Rounding Bottom on 1D (BREAKOUT CONFIRMED) — target ₹5773.75

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

Composite score 52.47 (BUY) with 86.2% confidence

20/50 Bullish Cross detected 4 day(s) ago

Technical Analysis

Analysis from 2026-07-10

Confidence

86%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

5516.15

EMA50

5459.83

EMA200

5441.41

Price Action

UPTREND

BULLISH

Higher Highs6

Higher Lows7

Lower Highs3

Lower Lows2

Support & Resistance Levels

Resistance (Above)

₹5775.00

₹5905.50

Support (Below)

₹5662.00

₹5577.12

₹5469.25

₹5360.40

₹5125.05

Volume Analysis

TrendINCREASING

Change+88.00%

Unusual VolumeNo

Recent MA Crossovers

20/50 Bullish Cross

4 days ago

BUY

Stop Loss Levels

Fixed Risk

1% Risk₹5612.81

3% Risk₹5499.41

5% Risk₹5386.02

7% Risk (Custom)

₹5272.63

Technical Levels

1x ATR (Volatility)₹5550.22

2x ATR (Swing)₹5430.94

3x ATR (Trend)₹5311.66

Immediate Support₹5662.00

Moving Averages

EMA 9 (Short-term)₹5591.29

EMA 20 (Medium-term)₹5516.15

EMA 50 (Trend)₹5459.83

EMA 200 (Long-term)₹5441.41

Financials

Financial Analysis

Metric	Mar '25	Jun '25	Sep '25	Dec '25
Revenue	₹2,983.9 Cr	₹3,371.1 Cr	₹4,001 Cr	₹3,736.8 Cr
Net Profit	₹305.9 Cr	₹664.3 Cr	₹765.1 Cr	₹636 Cr
EPS	—	₹55.56	₹63.99	₹53.19
Operating Profit	₹502.8 Cr	₹888.5 Cr	₹1,024.5 Cr	₹918.3 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change	P/E Ratio	Market Cap
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,935.50	-0.17%	40.2	₹4.64L Cr large Cap
DIVISLAB	Divi's Laboratories Limited	₹6,836.00	+0.34%	70.4	₹1.81L Cr large Cap
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,901.50	+0.07%	77.5	₹1.66L Cr large Cap
CIPLA	Cipla Limited	₹1,439.40	-0.13%	30.1	₹1.16L Cr large Cap
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,150.80	-0.71%	23.0	₹1.16L Cr large Cap
LUPIN	Lupin Limited	₹2,496.30	-0.28%	21.4	₹1.14L Cr mid Cap
MANKIND	Mankind Pharma Limited	₹2,525.10	-0.27%	54.3	₹1.04L Cr mid Cap
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,244.30	-1.99%	25.6	₹1.04L Cr large Cap
AUROPHARMA	Aurobindo Pharma Limited	₹1,564.70	-1.43%	26.1	₹90.88K Cr mid Cap
LAURUSLABS	Laurus Labs Limited	₹1,537.80	+2.02%	91.5	₹83.02K Cr mid Cap
ALKEM	Alkem Laboratories Limited	₹5,669.50	+0.37%	28.7	₹67.79K Cr mid Cap

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
20 Feb 2026	Interim Dividend - Rs 43 Per Share	INTERIM_DIVIDEND
08 Aug 2025	Dividend - Rs 8 Per Share	DIVIDEND
14 Feb 2025	Interim Dividend - Rs 37 Per Share	INTERIM_DIVIDEND
09 Aug 2024	Dividend - Rs 5 Per Share	DIVIDEND
16 Feb 2024	Interim Dividend - Rs 35 Per Share	INTERIM_DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
02 Jul 2026	Copy of Newspaper Publication
01 Jul 2026	Action(s) taken or orders passed
30 Jun 2026	Copy of Newspaper Publication
29 Jun 2026	Analysts/Institutional Investor Meet/Con. Call Updates
29 Jun 2026	Analysts/Institutional Investor Meet/Con. Call Updates

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
28 May 2026	Financial Results/Dividend
28 May 2026	Board Meeting Intimation	XBRL
13 Feb 2026	Board Meeting Intimation	XBRL
13 Feb 2026	Financial Results/Dividend
13 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for ALKEM

View All

NEWS

positive

Business Standard - Markets 3d ago

Alkem Laboratories Ltd gains for third consecutive session

Alkem Laboratories Ltd is quoting at Rs 5680, up 1.46% on the day as on 12:49 IST on the NSE. The stock is up 18.31% in last one year as compared to a 4.13% drop in NIFTY and a 16.41% drop in the Nifty Pharma index.

ALKEMAONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFPHARMABEESPVTBANIETFFinancial ServicesHealthcare

Read full story

Indian pharma firms gear up to supply key cancer drug to US

negative

ET Markets - Industry 17d ago

Indian pharma firms gear up to supply key cancer drug to US

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading companies like Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to supply the medicine. The US FDA has reached out to Indian pharmaceutical bodies, seeking manufacturers capable of producing the drug in various strengths to ensure availability for cancer patients.

ALKEMAUROPHARMACIPLAVITALChemicalsHealthcare

Read full story

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox

neutral

Google News - India Markets 18d ago

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supplyUpstox

ALKEMCIPLAHealthcare

Read full story

ALKEM

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Recent MA Crossovers

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for ALKEM

Alkem Laboratories Ltd gains for third consecutive session

Indian pharma firms gear up to supply key cancer drug to US

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox

Frequently Asked Questions

What is the current share price of Alkem Laboratories Limited (ALKEM)?

What is the technical sentiment for ALKEM stock?

What is the 52-week high and low for Alkem Laboratories Limited?

Which sector does Alkem Laboratories Limited belong to?

What is the market capitalization of ALKEM?